Pharma News

A phase 3 clinical trial has found that finerenone, a nonsteroidal mineralocorticoid receptor antagonist, produces a significantly greater reduction in a key marker of kidney damage compared to placebo in adults with Type 1 diabetes and chronic kidney disease (CKD). The results were published on March 5, 2026 in the New England Journal of Medicine.

For anyone who has spent time hiking wooded trails, camping, or simply walking through tall grass, the fear of a tiny tick causing outsized harm is very real. Lyme disease has quietly become one of the most common infectious diseases in the Northern Hemisphere, and yet, for years, doctors have had no vaccine to offer patients. That may be about to change.

On March 23, 2026, Pfizer and French biotech Valneva announced results from their landmark Phase 3 VALOR trial and the numbers are genuinely encouraging.

In a balanced move aimed at strengthening drug quality while supporting industry practicality, the Drugs Technical Advisory Board (DTAB) has taken key decisions regarding the implementation of the revised Schedule M during its 93rd meeting.

In a significant development for India’s pharmaceutical regulatory landscape, the Drugs Technical Advisory Board (DTAB) has reaffirmed its position to include all antimicrobial drugs under the definition of “New Drugs” as per the New Drugs and Clinical Trials Rules, 2019.

The decision was taken during the 93rd meeting of DTAB held on February 16, 2026, at FDA Bhawan, New Delhi, conducted in a hybrid format. The board reviewed and approved the Action Taken Report (ATR) from its previous (92nd) meeting held on April 24, 2025.

The Himachal Institute of Pharmacy, Paonta Sahib, in association with the Himachal Pradesh State APTI Branch, successfully organized a two-day International Conference on the theme “Pharmacy Beyond Borders: Translating Innovation into Impact for Global Health” on February 27–28, 2026. The event witnessed enthusiastic national and international participation, with more than 1,200 registered delegates representing 22 states and five countries.

SIMATS College of Pharmacy, Saveetha Institute of Medical and Technical Sciences (Saveetha University), Chennai, celebrated the National Pharmacy Education Day in accordance with the directions of the Pharmacy Council of India (PCI), held during March 5, 2026 at Kurinji Hall, Saveetha Medical College and Hospital, Chennai. 

The U.S. Food and Drug Administration has approved a new treatment combination of teclistamab‑cqyv with daratumumab and hyaluronidase‑fihj for adult patients with relapsed or refractory Multiple Myeloma. The approval offers a new therapeutic option for patients whose disease has returned or stopped responding after earlier treatments.

India’s drug regulator has issued a public advisory after a consignment of insulin pens manufactured by Sanofi India Limited was reported stolen during transportation, raising concerns about potential risks if the products enter the market through unauthorized channels.